Novigen Peptides
Product Usage Guides ← Home 🛒 Shop
Official Product Documentation

Novigen Retatrutide®
Usage Guide

Please read all instructions carefully before use. Follow each step precisely to ensure safe and effective administration of your Novigen Retatrutide® pre-filled pen.

Retatrutide®Pre-filled injection pen  ·  Once weekly
⚠ Important — Read Before Use

This product is for use under the guidance of a qualified healthcare professional only. Keep out of reach of children. Do not use if the seal is broken or the solution appears cloudy or discoloured. Contact your prescriber immediately if you experience unexpected side effects.

🔬 Research Chemical Notice: Retatrutide is not yet approved for human use by any regulatory authority. This product is a research chemical intended for investigational purposes only. It has not completed clinical trials and its long-term safety profile in humans has not been fully established. Use is entirely at the individual's own risk.

Section 01 – Before You Begin
1

Check Your Pen

Before each use, inspect the pen carefully. Check the expiry date on the pen label. The solution should be clear and colourless or almost colourless. Do not use if you notice particles, cloudiness, or the seal is broken.

2

Allow the Pen to Reach Room Temperature

Remove from the refrigerator and allow to sit at room temperature for approximately 30 minutes before injecting. Cold solution may cause discomfort.

Do not warm using hot water or a microwave.
3

Wash Your Hands

Thoroughly wash and dry your hands before handling the pen or preparing the injection site to reduce the risk of contamination.

4

Gather Your Supplies

You will need your Novigen Retatrutide® pen, a new sterile needle, an alcohol swab, and a sharps disposal container. Always use a new needle for each injection.

Section 02 – Dosage
5

Starting Dose & Titration

Begin with a starting dose of 2mg once weekly. Your dose may be increased by 1mg at a time when clinically appropriate and as tolerated. Only increase under guidance of your prescriber.

Starting Dose2mgonce weekly
Titration Step+1mgwhen tolerated
Pen Capacity40mgper pen
~20 doses per pen at 2mg Never increase your dose without consulting your prescriber.
6

Injection Day

Administer on the same day each week, at any time of day, with or without food. If changing your weekly day, ensure at least 4 days have passed since your last injection.

7

If You Miss a Dose

If within 4 days of the missed dose, administer as soon as possible. If more than 4 days have passed, skip and resume on your next scheduled day. Do not double dose.

Section 03 – Administering the Injection
8

Choose Your Injection Site

Inject subcutaneously into the abdomen, front of the thigh, or upper arm. Rotate sites each week to avoid irritation.

Do not inject into a vein or muscle. Avoid bruised, red, tender, or broken skin.
9

Prepare the Injection Site

Clean the chosen area with an alcohol swab using a circular motion. Allow to air dry completely before injecting.

10

Attach the Needle & Check the Dose Counter

Attach a new sterile needle to the pen. Confirm the correct dose is set on the dose counter before injecting.

If you are unable to read the dose counter or have poor eyesight, do not use the pen without assistance from a person with good eyesight or your healthcare provider.

11

Inject the Dose

Gently pinch a fold of skin at the cleaned site. Insert the needle at 90° (or 45° if you have very little body fat). Press and hold the injection button until the dose counter reads zero. Keep the needle in skin for at least 6 seconds, then remove.

12

Remove & Dispose of the Needle Safely

Remove the needle and place directly into a sharps container. Never recap with two hands or dispose of in household waste. Replace the pen cap after every use.

Section 04 – Storage
13

Before Opening

Store unused pens in the refrigerator at 2°C to 8°C. Do not freeze. Keep away from the cooling element. Protect from light.

14

After First Use

Once in use, the pen may be kept at room temperature (below 30°C) for up to 6 weeks, or refrigerated for up to 16 weeks. Always replace the pen cap to protect from light.

Do not freeze a pen that has already been used.
Section 05 – Possible Side Effects
15

Common Side Effects

These typically resolve as your body adjusts and are most common when starting or after a dose increase.

NauseaVomitingDiarrhoeaConstipationStomach painIndigestionReduced appetiteFatigueDizziness
16

Serious Side Effects — Seek Medical Attention

Stop use and contact your prescriber or seek urgent medical attention if you experience any of the following:

Severe abdominal painDifficulty breathing or swallowingSwelling of face, lips or throatSigns of low blood sugarRapid heartbeatVision changes
Official Product Documentation

Novigen Glow
Usage Guide

A premium regenerative blend formulated for skin health, collagen support, tissue repair, and anti-ageing wellness. Please read all instructions before use.

Glow 70mgPre-filled injection pen  ·  Once daily
GHK-Cu 50mgTB-500 10mgBPC-157 10mg
⚠ Important — Read Before Use

This product is for use under the guidance of a qualified healthcare professional only. Keep out of reach of children. Do not use if the seal is broken or the solution appears cloudy or discoloured. Contact your prescriber immediately if you experience unexpected side effects.

🔬 Research Chemical Notice: Novigen Glow contains peptide compounds (GHK-Cu, TB-500, BPC-157) that have not been approved for human use by any regulatory authority. These are research chemicals that have not undergone formal human clinical trials in this combined formulation. This product is intended for investigational purposes only. Use is entirely at the individual's own risk.

Section 01 – About Glow 70mg
1

What is Glow 70mg?

Novigen Glow is a carefully formulated regenerative peptide blend combining three synergistic compounds. GHK-Cu (50mg) supports collagen synthesis, skin elasticity, and cellular repair. TB-500 (10mg) promotes tissue regeneration, flexibility, and recovery. BPC-157 (10mg) supports gut health, tissue healing, and anti-inflammatory processes.

Each pen contains 70mg total — approximately a 30-day supply at the standard 2.3mg daily dose.

Section 02 – Before You Begin
2

Check Your Pen

Before each use, inspect the pen carefully. Check the expiry date on the pen label. The solution should be clear and colourless or almost colourless. Do not use if you notice particles, cloudiness, or the seal is broken.

3

Allow the Pen to Reach Room Temperature

Remove from the refrigerator and allow to sit at room temperature for approximately 15–20 minutes before injecting.

Do not warm using hot water or a microwave.
4

Wash Your Hands

Thoroughly wash and dry your hands before handling the pen or preparing the injection site to reduce the risk of contamination.

5

Gather Your Supplies

You will need your Novigen Glow pen, a new sterile needle, an alcohol swab, and a sharps disposal container. Always use a new needle for each injection.

Section 03 – Dosage
6

Daily Dose

Administer 2.3mg once daily via subcutaneous injection. This is a fixed dose — do not adjust without consulting your prescriber.

Daily Dose2.3mgonce daily
Pen Capacity70mgper pen
Supply~30daysper pen
7

Best Time to Inject

Administer at the same time each day for consistency. Many users prefer morning administration. You may inject with or without food.

8

If You Miss a Dose

If you miss your daily injection, administer it as soon as you remember on the same day. If you only remember the following day, skip the missed dose and continue with your normal schedule. Do not double dose.

Section 04 – Administering the Injection
9

Choose Your Injection Site

Inject subcutaneously into the abdomen, front of the thigh, or upper arm. Rotate sites daily to avoid skin irritation.

Do not inject into a vein or muscle. Avoid bruised, red, tender, or broken skin.
10

Prepare the Injection Site

Clean the chosen area with an alcohol swab using a circular motion. Allow to air dry completely before injecting.

11

Attach the Needle & Check the Dose

Attach a new sterile needle to the pen. Confirm the correct dose is set before injecting. If unsure, consult your prescriber before proceeding.

12

Inject the Dose

Gently pinch a fold of skin at the cleaned injection site. Insert the needle at a 90° angle (or 45° if you have very little body fat). Press and hold the injection button until the dose counter reads zero. Keep the needle in place for at least 6 seconds, then remove.

13

Remove & Dispose of the Needle Safely

Carefully remove the needle and place directly into a sharps disposal container. Never recap with two hands or dispose of in household waste. Replace the pen cap after every use.

Section 05 – Storage
14

Before Opening

Store unused pens in the refrigerator at 2°C to 8°C. Do not freeze. Protect from light and keep away from the cooling element.

15

After First Use

Once in use, keep the pen refrigerated at 2°C to 8°C. Always replace the pen cap after each use. Use within 30 days of first opening.

Do not freeze a pen that has already been used.
Section 06 – Possible Side Effects
16

Common Side Effects

Most side effects are mild and localised. They typically resolve with continued use as the body adjusts.

Mild injection site rednessTemporary itchingMinor swelling at siteMild fatigueTemporary flushingMild nausea
17

Serious Side Effects — Seek Medical Attention

Stop use and contact your prescriber or seek urgent medical attention if you experience any of the following:

Severe allergic reactionDifficulty breathing or swallowingSwelling of face, lips or throatSevere or persistent skin reactionChest pain or palpitations
Official Product Documentation

Novigen Tirzepatide®
Usage Guide

Please read all instructions carefully before use. Follow each step precisely to ensure safe and effective administration of your Novigen Tirzepatide® pre-filled pen.

Tirzepatide®Pre-filled injection pen  ·  Once weekly
⚠ Important — Read Before Use

This product is for use under the guidance of a qualified healthcare professional only. Keep out of reach of children. Do not use if the seal is broken or the solution appears cloudy or discoloured. Contact your prescriber immediately if you experience unexpected side effects.

Section 01 – Before You Begin
1

Check Your Pen

Before each use, inspect the pen carefully. Check the expiry date printed on the pen label. Do not use if expired. The solution should be clear and colourless or almost colourless. Do not use if you notice particles, cloudiness, or the seal is broken.

2

Allow the Pen to Reach Room Temperature

Remove from the refrigerator and allow to sit at room temperature for approximately 30 minutes before injecting. Injecting cold solution may cause unnecessary discomfort.

Do not warm using hot water or a microwave.
3

Wash Your Hands

Thoroughly wash and dry your hands before handling the pen or preparing the injection site to reduce the risk of contamination.

4

Gather Your Supplies

You will need your Novigen Tirzepatide® pen, a new sterile needle, an alcohol swab, and a sharps disposal container. Always use a new needle for each injection — never reuse needles.

5

Check the Pen & Needle

Attach a new needle to the pen. Check the dose counter to confirm the correct dose is set. Never use a bent or damaged needle. Your pen is designed to be used with disposable needles (29–31 gauge) — up to 12 needles are included in the box.

If you have poor eyesight or cannot read the dose counter, do not use the pen without assistance from a person with good eyesight or your healthcare provider.
Section 02 – Dosage
6

Dose Escalation Schedule

Novigen Tirzepatide® is started at a low dose and increased gradually to minimise gastrointestinal side effects. Your prescriber will guide your individual escalation schedule.

Starting Dose2.5mgonce weekly × 4 wks
Step 25mgonce weekly × 4 wks
Pen Size15mgper pen
15mg pen = 6 doses at 2.5mg Further increases to 7.5mg, 10mg, 12.5mg, and 15mg may be made in 4-weekly intervals as directed by your prescriber.
7

Injection Day

Administer on the same day each week, at any time of day, with or without food. If you wish to change your injection day, ensure at least 3 days have passed since your last injection.

8

If You Miss a Dose

If you miss a dose and it is within 4 days of the missed injection, administer it as soon as possible. If more than 4 days have passed, skip the missed dose and resume on your next scheduled day. Do not inject a double dose.

9

Stopping Treatment

Do not stop using Novigen Tirzepatide® without first consulting your prescriber. Blood sugar levels and body weight may be affected when stopping treatment. Your doctor may advise a gradual reduction.

Section 03 – Administering the Injection
10

Choose Your Injection Site

Novigen Tirzepatide® is given as a subcutaneous (under the skin) injection. Recommended sites are the abdomen (at least 5cm from the navel), the front of the thigh, or the upper arm. Rotate sites each week to avoid skin irritation.

Do not inject into a vein or muscle. Avoid areas that are bruised, red, tender, swollen, or have broken skin.
11

Prepare the Injection Site

Clean the chosen area with an alcohol swab using a circular motion. Allow to air dry completely before injecting — do not blow or fan it dry.

12

Inject the Dose

Remove the inner needle cap. Gently pinch a fold of skin at the cleaned site. Insert the needle fully at a 90° angle. Press and hold the injection button until the dose counter reads zero. Keep the needle in place for at least 10 seconds to ensure full dose delivery, then remove.

You may hear a click when the injection is complete. Keep holding until the counter reads zero regardless.
13

Replace the Cap & Dispose Safely

Carefully remove the needle and place directly into a sharps disposal container. Never recap with two hands. Replace the pen cap after every use. Do not share your pen with anyone else.

Section 04 – Special Situations
14

Hypoglycaemia (Low Blood Sugar)

If using this product alongside a sulphonylurea or insulin, the risk of low blood sugar is increased. Warning signs include cold sweats, shakiness, pale skin, rapid heartbeat, confusion, or unusual hunger. Your prescriber may need to reduce your insulin or sulphonylurea dose.

Always carry a fast-acting glucose source (e.g. glucose tablets, fruit juice) if you are at risk of hypoglycaemia. Inform your prescriber if you experience these symptoms.

15

Driving & Operating Machinery

Hypoglycaemia can impair your ability to concentrate and react. If you experience symptoms of low blood sugar, do not drive or operate machinery until your blood sugar has returned to normal.

16

Pregnancy & Breastfeeding

Do not use this product if you are pregnant, planning to become pregnant, or breastfeeding. It is unknown whether Tirzepatide passes into breast milk. Contact your prescriber immediately if you become pregnant during treatment.

Section 05 – Storage
17

Before Opening

Store unused pens in the refrigerator at 2°C to 8°C. Do not freeze. Keep away from the cooling element inside the refrigerator. Protect from light.

18

After First Use

Once in use, the pen can be kept at room temperature (below 30°C) for up to 6 weeks, or stored in the refrigerator for up to 16 weeks. Keep the pen cap on when not in use to protect from light.

Do not freeze a pen that has already been used.
Section 06 – Possible Side Effects
19

Very Common & Common Side Effects

Most common during dose escalation. Eating smaller, lower-fat meals can help reduce gastrointestinal symptoms.

NauseaVomitingDiarrhoeaConstipationStomach painIndigestionBurpingBloatingReduced appetiteFatigueDizzinessWeight lossInjection site reactions
20

Serious Side Effects — Seek Medical Attention

Stop use and contact your prescriber or seek urgent medical attention if you experience any of the following:

Severe abdominal pain (possible pancreatitis)Difficulty swallowing or breathingSwelling of face, lips, tongue or throatRapid or irregular heartbeatSigns of low blood sugarSudden vision changesSevere skin reaction

Acute pancreatitis has been reported with GLP-1/GIP receptor agonists. Severe, persistent abdominal pain — particularly if it radiates to the back — should be treated as a medical emergency.

Official Product Documentation

Novigen HGH
Usage Guide

Recombinant Human Growth Hormone (rHGH) produced via E. coli expression. Please read all instructions carefully before use and only administer under the supervision of a qualified healthcare professional.

rHGH 120IUPre-filled injection pen  ·  Subcutaneous
⚠ Important — Read Before Use

This product is for use under the guidance of a qualified healthcare professional only. Off-label dosing information provided is based on widely referenced clinical and community protocols. It is not approved by the MHRA or FDA for anti-ageing, body composition, or performance purposes. All use should be medically supervised. Keep out of reach of children.

Section 01 – About This Product
1

What is Novigen rHGH 120IU?

Novigen rHGH is a recombinant human growth hormone produced using Escherichia coli (E. coli) bacterial expression technology. This produces a 191 amino acid sequence identical to endogenous human growth hormone. Each pen contains 120IU of somatropin.

1mg is approximately equal to 3IU. 1IU is approximately equal to 0.33mg. Growth hormone is most effective when administered in the evening or post-exercise to align with the body's natural pulsatile secretion.

Section 02 – Dosage Tiers
2

Therapeutic — Wellness & Anti-Ageing

Tier 1 — Therapeutic
2 – 3 IU per day
Recommended for general wellbeing, anti-ageing, improved skin elasticity, bone density, joint health, and sleep quality. Low risk of side effects at this range. Suitable for long-term use under medical supervision.
120IU pen supply: ~40–60 days
This is the most commonly prescribed range for adults with age-related growth hormone decline.
3

Enhanced — Fat Loss & Body Composition

Tier 2 — Enhanced
4 – 6 IU per day
Used for accelerated fat loss, improved body composition, increased energy, and enhanced recovery. At this range, splitting the dose (morning and evening) is recommended to reduce side effect risk. IGF-1 blood level monitoring is strongly advised.
120IU pen supply: ~20–30 days
Side effects become more likely above 4IU. Water retention, mild joint discomfort, and carpal tunnel symptoms may occur. These typically resolve with dose reduction.
4

Performance — Bodybuilding & Athletic

Tier 3 — Performance
7 IU+ per day
Used in performance and bodybuilding contexts for significant muscle hypertrophy support, aggressive fat loss, and enhanced recovery between training sessions. This range carries meaningfully higher risk and should only be considered by experienced individuals under close medical supervision with regular blood work.
120IU pen supply: ~15–17 days
Doses above 6IU significantly increase the risk of insulin resistance, acromegaly symptoms, and organ stress. Regular monitoring of blood glucose and IGF-1 levels is essential at this tier.
5

Dosing Frequency & Timing

Growth hormone is best administered once daily at Tier 1 doses. At Tier 2 and above, splitting into two doses (morning and evening, or post-workout and before bed) is widely recommended to better mimic the body's natural pulsatile release and reduce peak-related side effects.

Administering before bed is popular as it aligns with the body's largest natural GH pulse during deep sleep. Post-workout administration is also effective as exercise potentiates GH response.

Section 03 – Before You Begin
6

Check Your Pen

Before each use, inspect the pen carefully. Check the expiry date on the pen label. The solution should be clear and colourless. Do not use if you notice particles, cloudiness, or the seal is broken.

7

Allow to Reach Room Temperature

Remove from the refrigerator and allow to sit at room temperature for 15–20 minutes before injecting. Do not warm using hot water or a microwave.

8

Wash Your Hands

Thoroughly wash and dry your hands before handling the pen or preparing the injection site.

9

Gather Your Supplies

You will need your Novigen rHGH pen, a new sterile needle, an alcohol swab, and a sharps disposal container. Always use a new needle for each injection.

Section 04 – Administering the Injection
10

Choose Your Injection Site

Administer subcutaneously (under the skin) into the abdomen, front of the thigh, or upper arm. Rotate injection sites with each dose to avoid lipodystrophy (fatty tissue changes at the injection site).

Do not inject into a vein or muscle. Avoid bruised, red, or broken skin.
11

Prepare the Site

Clean the chosen area with an alcohol swab using a circular motion. Allow to air dry completely before injecting.

12

Inject the Dose

Attach a fresh sterile needle. Set the correct dose on the pen counter. Gently pinch a fold of skin, insert the needle at 90° (or 45° if lean), press and hold the button until the counter reads zero. Hold in place for 6 seconds before removing.

13

Dispose of the Needle Safely

Place the used needle directly into a sharps container. Never recap with two hands or dispose of in household waste. Replace the pen cap after every use.

Section 05 – Storage
14

Before Opening

Store unused pens in the refrigerator at 2°C to 8°C. Do not freeze. Protect from direct light. Keep away from the cooling element.

15

After First Use

Once in use, store refrigerated at 2°C to 8°C. Replace the pen cap after every use to protect from light. Use within 28 days of first opening.

Never freeze a pen that has been opened. Freezing will denature the protein and render it ineffective.
Section 06 – Possible Side Effects
16

Common Side Effects

More likely at higher doses or when starting treatment. Most resolve with dose adjustment.

Water retention / oedemaJoint discomfortCarpal tunnel symptomsMild headachesInjection site rednessFatigueMuscle achesTemporary blood sugar rise
17

Serious Side Effects — Seek Medical Attention

Stop use and contact your prescriber or seek urgent medical attention if you experience:

Signs of insulin resistance or diabetesSevere or persistent joint/bone painVision changesSevere headache or nauseaUnexplained swellingChest pain

Long-term use at high doses may contribute to acromegaly (enlargement of extremities), insulin resistance, and increased cardiovascular risk. Regular blood work including IGF-1, fasting glucose, and HbA1c is strongly recommended for anyone using above therapeutic doses.